Janux Therapeutics, Inc. ($JANX)
Filing Information
| Accession Number | 0001864158-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 3, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
442,772
Total Value
$110,828.56
P&L
+inf% (+$6,106,752.54)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 2, 2026 | Sale | 8,072 | $13.73 | $110,828.56 | 284,982 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 2, 2026 | Grant/Award | 96,600 | $0.00 | $0.00 | 381,582 | Direct | โ | View Details | |
Director | Stock option (right to buy) | Derivative | Jan 2, 2026 | Grant/Award | 338,100 | $0.00 | $0.00 | 338,100 | Direct | โ | View Details |